Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy

Clinical Oncology

Volumn 16, Issue 8, 2004, Pages 517-522

  Lee, L W ^a   McBain, C A ^a   Swindell, R ^a   Wylie, J P ^a   Cowan, R A ^a   Logue, John P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Prostate cancer; Radical prostatectomy; Radiotherapy; Salvage

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEMINAL VESICLE DISEASE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

AGED; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 8744234913     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.07.006     Document Type: Article

References (14)

1. www.cancerresearchuk.org
2. S.E. Oliver J.L. Donovan T.J. Peters S. Frankel F.C. Hamdy D.E. Neal Recent trends in the use of radical prostatectomy in England: The epidemiology of diffusion BJU Int 91 2003 331-336
3. P.A. Kupelian J. Katcher H.S. Levin et al. Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy Int J Radiat Oncol Biol Phys 37 1997 1043-1052
4. T.M. Pisanksy T.F. Kozelsky R.O. Myers et al. Radiotherapy for isolated serum prostate specific antigen elevation following prostatectomy for prostate cancer J Urol 163 2000 845-850
5. J.A. Cadeddu A.W. Partin T.L. DeWeese et al. Long term results of radiation therapy for prostate cancer recurrence following radical prostatectomy J Urol 159 1998 173-177
6. M.S. Anscher R. Clough R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first 10 years Int J Radiat Oncol Biol Phys 48 2000 369-375
7. M.J. Zelefsky E. Aschkenasy S. Kelsen et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 39 1997 327-333
8. D.J. Brenner A.A. Martinez G.K. Edmundson C. Mitchell H.D. Thames E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio) similar to late-responding tissue Int J Radiat Oncol Biol Phys 52 2002 6-13
9. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035-1041
10. G.G. Steel Basic clinical radiobiology 3rd edn 2002 Arnold London 136
11. J.A. Connolly K. Shinohara J.C. Presti Jr. et al. Local recurrence after prostatectomy: Characteristics in size, location and relationship to prostate-specific antigen and surgical margins Urology 47 1996 225-231
12. C.R. Pound A.W. Partin M.A. Eisenberger et al. Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591-1597
13. M.S. Anscher Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen Int J Cancer 96 2001 91-93
14. B.W. Corn K. Winter M.V. Pilepich Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group Urology 54 1999 495-502